Clinical Trials Logo

Citation(s)

  •   Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM
    The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
  •   Rizzo E
    Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn Schmiedebergs Arch Pharmacol. 2020 Jul;393(7):1153-1156. doi: 10.1007/s00210-020-01902-5. Epub 2020 May 27.

Evaluation of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of covid19

Details for clinical trial NCT04425863